Stroke Management Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Stroke Management Market to 2027 - Global Analysis and Forecasts by Type (Diagnostic, Therapeutic); Application (Ischemic Stroke, Haemorrhagic Stroke) and Geography

Report Code: TIPRE00003527 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
A restorative condition where blockage of veins causes' interference in the blood supply to the brain is called as stroke. Stroke can prompt the death of cerebrum cells or a person. A stroke is also called as a brain attack because it can occur quickly and needs immediate treatment. The incidence of stroke in the old age population is high, and it is one of the major causes of death in developed countries. According WHO estimates, stroke results in 17 million deaths annually. Also, according to the Centers for Disease Control and Prevention (CDC), strokes cause one out of every 20 deaths, with annual cost of around US$ 34 Bn in the U.S. Hence, it is necessary the early diagnosis and treatment management to restrict deaths from stroke. Steps of stroke management involves stroke prevention, and it leads to reduction in risk of recurrent strokes in patients.

MARKET DYNAMICS
Rising incidence of chronic diseases, increase in geriatric population, growing cases of diabetes and rising tobacco consuming population are likely to fuel the stroke management market during the forecast period. However, less awareness about stroke management and expensive treatment options, devices and drugs are predicted to restrict the market expansion in the near future.

MARKET SCOPE
The "Global Stroke Management Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of stroke management market with detailed market segmentation by product, application, end user and geography. The global stroke management market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading stroke management market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global stroke management market is segmented on the type and application. Based on type, the market is segmented as diagnostic and therapeutic. The diagnostic segment is divided into Computed Tomography Scan (CT Scan), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography and Others. The therapeutic segment is divided into Tissue Plasminogen Activator, Anticoagulant, Antiplatelet and Antihypertensive. Based on the application, the global stroke management market is segmented into Ischemic Stroke and Haemorrhagic Stroke.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global stroke management market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The stroke management market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting stroke management market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Stroke management market in these regions.

MARKET PLAYERS
The reports cover key developments in the stroke management market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from stroke management market are anticipated to lucrative growth opportunities in the future with the rising demand for stroke management in the global market. Below mentioned is the list of few companies engaged in the stroke management market.

The report also includes the profiles of key stroke management market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Abbott Laboratories
  • B Braun Melsungen AG
  • Boston Scientific Corp.
  • Bristol-Myers Squibb
  • Cardinal Health
  • Medtronic Plc.
  • GlaxoSmithKline Plc.
  • GE Healthcare
  • Merck
  • Koninklijke Philips N.V.
  • Siemens Healthcare
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.



TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Stroke Management Market - By Type
1.3.2 Stroke Management Market - By Application
1.3.3 Stroke Management Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. STROKE MANAGEMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. STROKE MANAGEMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. STROKE MANAGEMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. STROKE MANAGEMENT - GLOBAL MARKET OVERVIEW
6.2. STROKE MANAGEMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. STROKE MANAGEMENT MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. DIAGNOSTIC
7.3.1. Overview
7.3.2. Diagnostic Market Forecast and Analysis
7.3.3. Computed Tomography Scan (CT Scan) Market
7.3.3.1. Overview
7.3.3.2. Computed Tomography Scan (CT Scan) Market Forecast and Analysis
7.3.4. Magnetic Resonance Imaging (MRI) Market
7.3.4.1. Overview
7.3.4.2. Magnetic Resonance Imaging (MRI) Market Forecast and Analysis
7.3.5. Carotid Ultrasound Market
7.3.5.1. Overview
7.3.5.2. Carotid Ultrasound Market Forecast and Analysis
7.3.6. Cerebral Angiography Market
7.3.6.1. Overview
7.3.6.2. Cerebral Angiography Market Forecast and Analysis
7.3.7. Electrocardiography Market
7.3.7.1. Overview
7.3.7.2. Electrocardiography Market Forecast and Analysis
7.3.8. Echocardiography Market
7.3.8.1. Overview
7.3.8.2. Echocardiography Market Forecast and Analysis
7.3.9. Others Market
7.3.9.1. Overview
7.3.9.2. Others Market Forecast and Analysis
7.4. THERAPEUTIC
7.4.1. Overview
7.4.2. Therapeutic Market Forecast and Analysis
7.4.3. Tissue Plasminogen Activator Market
7.4.3.1. Overview
7.4.3.2. Tissue Plasminogen Activator Market Forecast and Analysis
7.4.4. Anticoagulant Market
7.4.4.1. Overview
7.4.4.2. Anticoagulant Market Forecast and Analysis
7.4.5. Antiplatelet Market
7.4.5.1. Overview
7.4.5.2. Antiplatelet Market Forecast and Analysis
7.4.6. Antihypertensive Market
7.4.6.1. Overview
7.4.6.2. Antihypertensive Market Forecast and Analysis
8. STROKE MANAGEMENT MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ISCHEMIC STROKE
8.3.1. Overview
8.3.2. Ischemic Stroke Market Forecast and Analysis
8.4. HAEMORRHAGIC STROKE
8.4.1. Overview
8.4.2. Haemorrhagic Stroke Market Forecast and Analysis
9. STROKE MANAGEMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Stroke Management Market Overview
9.1.2 North America Stroke Management Market Forecasts and Analysis
9.1.3 North America Stroke Management Market Forecasts and Analysis - By Type
9.1.4 North America Stroke Management Market Forecasts and Analysis - By Application
9.1.5 North America Stroke Management Market Forecasts and Analysis - By Countries
9.1.5.1 United States Stroke Management Market
9.1.5.1.1 United States Stroke Management Market by Type
9.1.5.1.2 United States Stroke Management Market by Application
9.1.5.2 Canada Stroke Management Market
9.1.5.2.1 Canada Stroke Management Market by Type
9.1.5.2.2 Canada Stroke Management Market by Application
9.1.5.3 Mexico Stroke Management Market
9.1.5.3.1 Mexico Stroke Management Market by Type
9.1.5.3.2 Mexico Stroke Management Market by Application
9.2. EUROPE
9.2.1 Europe Stroke Management Market Overview
9.2.2 Europe Stroke Management Market Forecasts and Analysis
9.2.3 Europe Stroke Management Market Forecasts and Analysis - By Type
9.2.4 Europe Stroke Management Market Forecasts and Analysis - By Application
9.2.5 Europe Stroke Management Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Stroke Management Market
9.2.5.1.1 Germany Stroke Management Market by Type
9.2.5.1.2 Germany Stroke Management Market by Application
9.2.5.2 France Stroke Management Market
9.2.5.2.1 France Stroke Management Market by Type
9.2.5.2.2 France Stroke Management Market by Application
9.2.5.3 Italy Stroke Management Market
9.2.5.3.1 Italy Stroke Management Market by Type
9.2.5.3.2 Italy Stroke Management Market by Application
9.2.5.4 Spain Stroke Management Market
9.2.5.4.1 Spain Stroke Management Market by Type
9.2.5.4.2 Spain Stroke Management Market by Application
9.2.5.5 United Kingdom Stroke Management Market
9.2.5.5.1 United Kingdom Stroke Management Market by Type
9.2.5.5.2 United Kingdom Stroke Management Market by Application
9.2.5.6 Rest of Europe Stroke Management Market
9.2.5.6.1 Rest of Europe Stroke Management Market by Type
9.2.5.6.2 Rest of Europe Stroke Management Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Stroke Management Market Overview
9.3.2 Asia-Pacific Stroke Management Market Forecasts and Analysis
9.3.3 Asia-Pacific Stroke Management Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Stroke Management Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Stroke Management Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Stroke Management Market
9.3.5.1.1 Australia Stroke Management Market by Type
9.3.5.1.2 Australia Stroke Management Market by Application
9.3.5.2 China Stroke Management Market
9.3.5.2.1 China Stroke Management Market by Type
9.3.5.2.2 China Stroke Management Market by Application
9.3.5.3 India Stroke Management Market
9.3.5.3.1 India Stroke Management Market by Type
9.3.5.3.2 India Stroke Management Market by Application
9.3.5.4 Japan Stroke Management Market
9.3.5.4.1 Japan Stroke Management Market by Type
9.3.5.4.2 Japan Stroke Management Market by Application
9.3.5.5 South Korea Stroke Management Market
9.3.5.5.1 South Korea Stroke Management Market by Type
9.3.5.5.2 South Korea Stroke Management Market by Application
9.3.5.6 Rest of Asia-Pacific Stroke Management Market
9.3.5.6.1 Rest of Asia-Pacific Stroke Management Market by Type
9.3.5.6.2 Rest of Asia-Pacific Stroke Management Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Stroke Management Market Overview
9.4.2 Middle East and Africa Stroke Management Market Forecasts and Analysis
9.4.3 Middle East and Africa Stroke Management Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Stroke Management Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Stroke Management Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Stroke Management Market
9.4.5.1.1 South Africa Stroke Management Market by Type
9.4.5.1.2 South Africa Stroke Management Market by Application
9.4.5.2 Saudi Arabia Stroke Management Market
9.4.5.2.1 Saudi Arabia Stroke Management Market by Type
9.4.5.2.2 Saudi Arabia Stroke Management Market by Application
9.4.5.3 U.A.E Stroke Management Market
9.4.5.3.1 U.A.E Stroke Management Market by Type
9.4.5.3.2 U.A.E Stroke Management Market by Application
9.4.5.4 Rest of Middle East and Africa Stroke Management Market
9.4.5.4.1 Rest of Middle East and Africa Stroke Management Market by Type
9.4.5.4.2 Rest of Middle East and Africa Stroke Management Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Stroke Management Market Overview
9.5.2 South and Central America Stroke Management Market Forecasts and Analysis
9.5.3 South and Central America Stroke Management Market Forecasts and Analysis - By Type
9.5.4 South and Central America Stroke Management Market Forecasts and Analysis - By Application
9.5.5 South and Central America Stroke Management Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Stroke Management Market
9.5.5.1.1 Brazil Stroke Management Market by Type
9.5.5.1.2 Brazil Stroke Management Market by Application
9.5.5.2 Argentina Stroke Management Market
9.5.5.2.1 Argentina Stroke Management Market by Type
9.5.5.2.2 Argentina Stroke Management Market by Application
9.5.5.3 Rest of South and Central America Stroke Management Market
9.5.5.3.1 Rest of South and Central America Stroke Management Market by Type
9.5.5.3.2 Rest of South and Central America Stroke Management Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. STROKE MANAGEMENT MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. B BRAUN MELSUNGEN AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BOSTON SCIENTIFIC CORP.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BRISTOL-MYERS SQUIBB
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CARDINAL HEALTH
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MEDTRONIC PLC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GLAXOSMITHKLINE PLC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. GE HEALTHCARE
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MERCK
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. KONINKLIJKE PHILIPS N.V.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
11.11. SIEMENS HEALTHCARE
11.11.1. Key Facts
11.11.2. Business Description
11.11.3. Products and Services
11.11.4. Financial Overview
11.11.5. SWOT Analysis
11.11.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. B Braun Melsungen AG
3. Boston Scientific Corp.
4. Bristol-Myers Squibb
5. Cardinal Health
6. Medtronic Plc.
7. GlaxoSmithKline Plc.
8. GE Healthcare
9. Merck
10. Koninklijke Philips N.V.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book